Drug factory · FDA FEI 3010142300

Gland Pharma Limited

Plot no: 49 & 50, J. N. Pharmacity, Parawada (M), Anakapalli District, India

India: 1

No problems found at FDA's last inspection, May 24, 2024.

No Action Indicated: inspectors found no objectionable conditions.

4 drug inspections on record since 2015: 3 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
TigecyclineMakes the active ingredient Apotex Corp. 60505-6098

FDA inspection history

EndedResultProgramProblems noted
May 24, 2024No problems foundDrug Quality Assurance—
Jan 27, 2023No problems foundDrug Quality Assurance—
Apr 20, 2018Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 29, 2015No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture; pack.